Bortezomib in Late Antibody-mediated Kidney Transplant Rejection

Trial Profile

Bortezomib in Late Antibody-mediated Kidney Transplant Rejection

Phase of Trial: Phase II

Latest Information Update: 27 Mar 2017

At a glance

  • Drugs Bortezomib (Primary)
  • Indications Transplant rejection
  • Focus Adverse reactions
  • Acronyms BORTEJECT
  • Most Recent Events

    • 22 Mar 2017 Status changed from active, no longer recruiting to completed.
    • 03 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by record.
    • 03 Mar 2015 Planned End Date changed from 1 Oct 2016 to 1 Feb 2017 as reported by record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top